Bullboard - Stock Discussion Forum Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

Add To Watchlist

NDAQ:APHA - Post Discussion

Aphria Inc. > Notable facts on Aphria leading into earnings

View:

Post by Savage97 on Sep 26, 2020 8:46am

Notable facts on Aphria leading into earnings

8 Wall Street analysts have issued ratings and price targets for Aphria in the last 12 months. There are currently 8 buy ratings for the stock, resulting in a consensus rating of "Buy." Their average twelve-month price target is $8.83 USD, predicting that the stock has a possible upside of 108.71%. The high price target for APHA is $11.00 and the low price target for APHA is $7.00. Aphria has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. In the past three months, Aphria insiders have not sold or bought any company stock. Only 9.57% of the stock of Aphria is held by institutions. Aphria has a P/B Ratio of 0.81. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

360